DexCom, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – DXCM

The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom ” or “the Company”) (NASDAQ: DXCM ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DXCM during the […]

Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026

Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026 EMBOLD data to serve as basis of efficacy and safety following discussion with the FDA GlobeNewswire December 11, 2025 BOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a

James Hardie Industries plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – JHX

The DJS Law Group reminds investors of a class action lawsuit against James Hardie Industries plc (“James Hardie ” or “the Company”) (NYSE: JHX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of

Cemtrex Highlights Profitability Focus, Strategic Transformation, and Progress Toward Portfolio Expansion

Cemtrex Highlights Profitability Focus, Strategic Transformation, and Progress Toward Portfolio Expansion GlobeNewswire December 11, 2025 Hauppauge, NY, Dec. 11, 2025 (GLOBE NEWSWIRE) — Cemtrex, Inc. (Nasdaq: CETX, CETXP) (“Cemtrex” or the “Company”), a diversified technology company operating in security and industrial markets, today provided a corporate update as it continues a multi-year transformation focused on

QuestionPro Achieves ISO 42001 Certification, Strengthening Commitment to Ethical and Responsible AI Management

QuestionPro Achieves ISO 42001 Certification, Strengthening Commitment to Ethical and Responsible AI Management Certification reinforces transparency, security, and accountability across QuestionPro's AI-enabled research and insights ecosystem GlobeNewswire December 11, 2025 AUSTIN, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) — QuestionPro, a global leader in online survey and research technology, announced that it has been awarded the

Premier Air Charter Strengthens Fleet with Challenger 604 Acquisition

Premier Air Charter Strengthens Fleet with Challenger 604 Acquisition GlobeNewswire December 11, 2025 Strategic expansion underscores commitment to growth and enhanced charter capacity, with the aircraft entering service in the coming weeks. CARLSBAD, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Premier Air Charter Holdings Inc. (OTCID: PREM) (“Premier Air Charter,” “Premier,” “PAC,” or the “Company”)

Hope for PDCD Foundation Delivers Petition to FDA Urging Approval of the First Targeted PDCD Treatment

Hope for PDCD Foundation Delivers Petition to FDA Urging Approval of the First Targeted PDCD Treatment Petition Rapidly Garnered More than 17,000 Signatures in Under 2 Months GlobeNewswire December 11, 2025 FOLSOM, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — The Hope for PDCD Foundation, a parent-led patient advocacy group dedicated to advancing research and treatments

ViroMissile Announces First-in-Human Phase I Trial of IDOV-Immune for Advanced Solid Tumors

ViroMissile Announces First-in-Human Phase I Trial of IDOV-Immune for Advanced Solid Tumors Study examines the safety and early efficacy of an oncolytic virus via a single intravenous dose GlobeNewswire December 11, 2025 SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) — ViroMissile, Inc., a cancer immunotherapy company pioneering the IDOV(TM) (Intravenously Deliverable Oncolytic Virus) platform, today

Oxford Lane Capital Corp. Provides November 2025 Net Asset Value Update

Oxford Lane Capital Corp. Provides November 2025 Net Asset Value Update GlobeNewswire December 11, 2025 GREENWICH, Conn., Dec. 11, 2025 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (the “Company,” “we,” or “our”) today announced the following net asset value

Stryker declares an $0.88 per share quarterly dividend

Stryker declares an $0.88 per share quarterly dividend GlobeNewswire December 11, 2025 Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing

Scroll to Top